Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Terlipressin vs other vasoactive drugs

Serious adverse events · people with cirrhosis and hepatorenal syndrome

It is very uncertain whether terlipressin changes serious adverse events compared with other vasoactive drugs (very low certainty).

1 finding from 1 review

Terlipressin versus other vasoactive drugs for hepatorenal syndrome 2017 · Cochrane Headline outcomes only
RR 0.96 [0.88, 1.06]
474 participants
Very low

Terlipressin vs other vasoactive drugs

Non‐serious adverse events: diarrhoea or abdominal pain, or both · people with cirrhosis and hepatorenal syndrome

It is very uncertain whether terlipressin changes non‐serious adverse events: diarrhoea or abdominal pain, or both compared with other vasoactive drugs (very low certainty).

1 finding from 1 review

Terlipressin versus other vasoactive drugs for hepatorenal syndrome 2017 · Cochrane Headline outcomes only
RR 3.5 [1.19, 10.27]
221 participants
Very low